*******************************************
RIKEN BioResource Research Center Cell Bank
MAILNEWS 20251006
https://cell.brc.riken.jp/en/
*******************************************
RIKEN BioResource Research Center (BRC) is pleased to update you with
the latest information.
====Contents========================
･ Newly cataloged cell lines (2025.10)
･ Exhibition Booth at the Conference
･ User publication
･ Introduction of relevant information
･ Editor's note
===================================
We hope you find the contents of this message of interest.
However, if you would prefer to unsubscribe from future e-mails,
please send an e-mail to cellbank.brc
riken.jp.
===================================
･ Newly cataloged cell lines (2025.10)
===================================
For more details, please refer to the link below.
https://cell.brc.riken.jp/en/new_resource
===================================
･ Exhibition Booth at the Conference
===================================
We will be exhibiting at the conference on the dates indicated below.
If you are looking for specific cell lines, please feel free to consult
with us. We also welcome inquiries regarding cell line deposition.
BioJapan2025
Oct. 8 (Wed.) - 10 (Fri.)
PACIFICO Yokohama
https://jcd-expo.jp/en/
The 48th Annual Meeting of the Molecular Biology Society of Japan
Dec. 3 (Wed.) - 5 (Fri.)
PACIFICO Yokohama
https://www.aeplan.jp/mbsj2025/en-index.html
The 54th Annual Meeting of the Japanese Society for Immunology
Dec. 10(Wed.) - 12(Fri.)
Arcrea HIMEJI (Himeji Culture and Convention Center)
https://www2.aeplan.co.jp/jsi2025/en/index.html
===================================
･ User publication
===================================
Research outcomes using the Hepa 1-6 cell line (RCB1638), which is
provided by this cell bank, have been published.
The Hepa 1-6 cell line is mouse-derived and expresses albumin,
alpha-fetoprotein, alpha-1-antitrypsin, and amylase. This cell line is a
model primarily used for hepatocellular carcinoma (HCC) research, and it
is considered useful for studying liver cancer progression and drug
response. Recently, research results using the Hepa 1-6 cell line were
published in a paper.
Immune evasion from macrophages by NEAT1-induced CD24 in liver cancer
https://doi.org/10.1038/s41388-025-03537-3
Hepa 1-6 cells are being used as a liver cancer cell model to analyze
why immunotherapy drugs are less effective against liver cancer.
===================================
･ Introduction of relevant information
===================================
Genetic diversity among the present Japanese population: evidence from
genotyping of human cell lines established in Japan.
https://doi.org/10.1007/s13577-024-01055-0
===================================
･ Editor's note
===================================
Thank you for reading MailNews 20251006 (Email Edition). We hope you
found this issue helpful. We will continue to provide useful information
and appreciate your support of our Cell Bank's activities.
This year's heat wave in Japan was brutal, but I'm relieved to finally
feel the autumn breeze. I plan to go out soon to enjoy the flavors of
the season. K.N.
===================================
*If you have any questions or comments, please send an e-mail to
cellbank.brcriken.jp.
*Content is subject to change without notice.
*All Rights Reserved.
_________________________________________
RIKEN BioResource Research Center Cell Bank
3-1-1 Koyadai, Tsukuba,
Ibaraki, 305-0074, Japan
cellbank.brcriken.jp
https://cell.brc.riken.jp/en/
https://x.com/RIKEN_BRC_en
_________________________________________
2025.10.06
